false
OasisLMS
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Login
Catalog
2026 Endocrine Case Management: Meet the Professor
2026 Endocrine Case Management: Meet the Professor ...
2026 Endocrine Case Management: Meet the Professor (PDF)
Back to course
Pdf Summary
ENDO 2026: Meet the Professor is a CME-accredited Endocrine Society case-based educational collection covering 40 endocrine, diabetes, and metabolism disorders. It emphasizes practical, guideline-based, individualized care across inpatient and outpatient settings.<br /><br />Major themes include obesity and adipose disorders, adrenal disease, bone/mineral metabolism, cardiovascular endocrinology, diabetes complications, neuroendocrinology, thyroid disease, reproductive endocrinology, and endocrine tumors. The chapters highlight newer therapies and evolving workflows such as GLP-1/GIP obesity medications, crinecerfont for congenital adrenal hyperplasia, palopegteriparatide for hypoparathyroidism, osteoanabolic sequencing, finerenone/SGLT2 inhibitors for diabetic kidney disease, and updated primary aldosteronism testing.<br /><br />The collection also covers several high-yield clinical scenarios: inpatient hyperglycemia management, GLP-1 receptor agonist use and safety considerations, pseudoendocrine disorders, ectopic Cushing syndrome, immune checkpoint inhibitor hypophysitis, acromegaly, pituitary apoplexy, hypotonic polyuria with copeptin-based testing, DSD, Prader-Willi hyperphagia, pituitary transition care, thyroid disease in pregnancy, hyperthyroidism, advanced thyroid cancer, and MEN1-related pancreatic neuroendocrine tumors.<br /><br />Core messages include:<br />- Use risk, stability, etiology, and patient context to guide treatment.<br />- Insulin remains the mainstay for inpatient hyperglycemia.<br />- CGM in the hospital requires confirmatory glucose testing or validated protocols.<br />- GLP-1 receptor agonists are not clearly linked to pancreatitis, and prior pancreatitis is not an absolute contraindication.<br />- Pseudoendocrine disorders lack evidence and can cause harm.<br />- Ectopic Cushing syndrome and pituitary apoplexy require urgent, multidisciplinary management.<br />- ICI hypophysitis often leads to permanent central adrenal insufficiency requiring replacement, not high-dose steroids.<br />- Advanced thyroid cancer care is increasingly genotype-directed.<br /><br />The activity offers up to 30 CME credits and ABIM MOC points, released June 13, 2026 and expiring December 31, 2028.
Keywords
endocrinology
diabetes
metabolism
CME-accredited
guideline-based care
obesity
adrenal disease
thyroid disease
pituitary disorders
GLP-1 therapies
×
Please select your language
1
English